Samuel Wu

Samuel Wu is a seasoned venture capital deal professional with a diverse network and firsthand experience in investing in, serving on boards of, and supporting over 20 biotech and medical device startup companies. His background includes management consulting at McKinsey, where he led teams in advising clients on corporate finance, commercialization, and portfolio strategy. With an MD and PhD from Stanford University School of Medicine and an A.B. from Harvard University, Samuel brings a unique blend of top-down strategic thinking and bottom-up analytical skills as a clinician and scientist. His specialties encompass biotechnology, pharmaceuticals, medical devices, business development, licensing, corporate finance, and strategy, with a keen interest in therapeutic areas like infectious disease, neuroscience, ophthalmology, inflammation, and immunology. Samuel Wu has held key positions such as Chief Business Officer at Blue Lake Biotechnology, Venture Partner at 7G BioVentures, Managing Partner at Acuris Partners, Interim Chief Medical Officer at Blue Lake Biotechnology, Managing Director at MedImmune Ventures, Principal at SV Life Sciences, and Engagement Manager at McKinsey & Company, along with a residency at UCLA Medical Center.